Although previous report found that Nrf2 was highly expressed in AML patients suffering positive mutations in FLT3-ITD, NPM1, KRAS, DNMT3A and IDH1/2 and so on, whether Nrf2 induced AML gene mutations by affecting MMR-related factors has not been evaluated. This evidence concerns the gene NFE2L2 and acute myeloid leukemia.